Schrodinger (NASDAQ:SDGR) CAO Sells $10,370.08 in Stock

Schrodinger, Inc. (NASDAQ:SDGR) CAO Jenny Herman sold 752 shares of the company’s stock in a transaction dated Tuesday, February 10th. The stock was sold at an average price of $13.79, for a total transaction of $10,370.08. Following the completion of the sale, the chief accounting officer owned 26,597 shares in the company, valued at $366,772.63. This represents a 2.75% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Schrodinger Stock Down 5.6%

SDGR stock traded down $0.67 during mid-day trading on Thursday, reaching $11.31. 3,352,994 shares of the company traded hands, compared to its average volume of 1,437,144. The firm’s 50 day moving average price is $16.85 and its 200 day moving average price is $18.52. The stock has a market cap of $833.15 million, a price-to-earnings ratio of -4.69 and a beta of 1.57. Schrodinger, Inc. has a fifty-two week low of $11.15 and a fifty-two week high of $28.47.

Institutional Trading of Schrodinger

A number of large investors have recently added to or reduced their stakes in SDGR. Massachusetts Financial Services Co. MA boosted its position in Schrodinger by 38.7% during the third quarter. Massachusetts Financial Services Co. MA now owns 2,072,433 shares of the company’s stock worth $41,573,000 after purchasing an additional 577,899 shares during the period. Capital Fund Management S.A. purchased a new stake in shares of Schrodinger during the 2nd quarter valued at approximately $1,486,000. Sumitomo Mitsui Trust Group Inc. boosted its holdings in Schrodinger by 24.8% in the 3rd quarter. Sumitomo Mitsui Trust Group Inc. now owns 4,554,569 shares of the company’s stock worth $91,365,000 after buying an additional 904,619 shares during the period. Nikko Asset Management Americas Inc. grew its stake in Schrodinger by 7.2% in the 2nd quarter. Nikko Asset Management Americas Inc. now owns 2,591,492 shares of the company’s stock valued at $52,089,000 after buying an additional 174,684 shares in the last quarter. Finally, Allspring Global Investments Holdings LLC grew its stake in Schrodinger by 17.7% in the 2nd quarter. Allspring Global Investments Holdings LLC now owns 205,319 shares of the company’s stock valued at $4,131,000 after buying an additional 30,948 shares in the last quarter. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts recently commented on the company. Bank of America raised Schrodinger from a “neutral” rating to a “buy” rating and set a $24.00 price target for the company in a research report on Monday, December 15th. KeyCorp lowered their target price on shares of Schrodinger from $28.00 to $25.00 and set an “overweight” rating for the company in a report on Thursday, January 8th. Wall Street Zen raised shares of Schrodinger from a “sell” rating to a “hold” rating in a research report on Saturday, January 31st. Weiss Ratings restated a “sell (e+)” rating on shares of Schrodinger in a report on Friday, January 9th. Finally, UBS Group assumed coverage on shares of Schrodinger in a research note on Wednesday, January 7th. They issued a “neutral” rating and a $18.00 price objective for the company. Five investment analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Hold” and an average target price of $24.33.

About Schrodinger

Schrödinger, Inc is a life sciences and materials discovery company that specializes in the application of physics-based computational platforms to accelerate drug discovery and advanced materials design. Founded in 1990 by Professor Richard A. Friesner, Schrödinger has developed a suite of proprietary software tools—such as Maestro for molecular modeling, Glide for molecular docking and Jaguar for quantum chemistry calculations—that enable scientists to predict molecular behavior with high accuracy.